Constance Hotels Services Limited (CHSL.mu) listed on the Stock Exchange of Mauritius under the Tourism sector has released it’s 2014 interim results for the first quarter.For more information about Constance Hotels Services Limited (CHSL.mu) reports, abridged reports, interim earnings results and earnings presentations, visit the Constance Hotels Services Limited (CHSL.mu) company page on AfricanFinancials.Document: Constance Hotels Services Limited (CHSL.mu) 2014 interim results for the first quarter.Company ProfileConstance Hotels Services Limited is a Mauritian company engaged in the management and ownership of hotels and resorts that include Ultimate hotels and Unique resorts in the Indian Ocean. The Ultimate hotels collection includes Constance Le Prince Maurice- Mauritius, Constance Lemuria- Seychelles and Constance Halaveli- Maldives whilst the company’s Unique resorts collection includes Constance Belle Mare Plage- Mauritius, Constance Ephelia- Seychelles, Constance Moofushi- Maldives and Constance Tsarabanjina- Madagascar. Constance Hotels Services Limited is listed on the Stock Exchange of Mauritius.
Allergy Therapeutics’ share price has risen 67% since March’s stock market crash Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Our 6 ‘Best Buys Now’ Shares “This Stock Could Be Like Buying Amazon in 1997” Image source: Getty Images. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Kirsteen has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. AIM-listed pharmaceuticals company Allergy Therapeutics (LSE:AGY) is enjoying recognition and a boost in its share price. Since falling 31% during last month’s stock market crash, the Allergy Therapeutics share price has climbed back up over 67%.Specialising in allergy vaccines, the group has gained recognition for its development of biodegradable adjuvants used to enhance the efficiency of allergy treatments.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Biotech stock to watchIt has a market cap of £86m, its price-to-earnings ratio (P/E) is 24 and earnings per share are less than 1p. It has no dividend and a debt ratio of 27%. The group saw 8% revenue growth in 2019 along with a 22% increase in pre-R&D operating profit.Many patients receiving allergy immunotherapy have an inadequate outcome because their immune system does not respond sufficiently well. Allergy Therapeutics uses adjuvants to boost patient immune responses to the injected allergens. These produce more antibodies and longer-lasting immunity, ultimately improving the efficiency of the vaccine.An academic paper published this week, acknowledged adjuvants MPL and MCT are each safe and effective. These two are used by the firm in its immunotherapies.Beating allergies from withinAllergy Therapeutics has developed immunotherapy options as an alternative to antihistamines and prescription steroids. These are used to treat hayfever, house dust mite allergy and allergies to pets. These immunotherapy treatments address the underlying cause of the allergy, rather than just its symptoms.Some of these, already brought to market, include products for combating pollen-related allergies, particularly to grasses, weeds and trees.Allergy Therapeutics has also been working on a peanut allergy vaccine for over three years. The successful creation of such a vaccine would save many lives and reduce anxiety for thousands more. Unfortunately, it is unlikely that the group will achieve this soon. Although it has massive potential, it is a very complex process. The first clinical trials of this vaccine are due to begin later this year. Although I imagine the coronavirus lockdown will now cause delays.The company also hopes to one day use its research and development progress to improve vaccines in areas such as influenza, cancers, and malaria.Allergy Therapeutics share price fluctuationsI think this is a very interesting company with the potential to create some admirable products. However, as with most companies listed on AIM, it comes with risk. This is because much depends on future outcomes rather than the here and now.The anticipation of clinical trials understandably brings excitement and positive sentiment. But there is no certainty that a trial will result in a positive outcome. A phase III trial of its birch allergy treatment failed last year. Nevertheless, if it can succeed with some of its ambitious projects, then it would be in a better position to tap into the lucrative US market, thought to be worth in excess of £1.6bn. Back in 2017, the Allergy Therapeutics share price reached a high of 38p, only for it to tumble thereafter. At 13p, these look like cheap shares to buy, but its P/E of 24 is high, which means the positive sentiment could already be priced into the share. I think it is a company worth watching and I hope Allergy Therapeutics succeeds in its vaccine developments. Enter Your Email Address See all posts by Kirsteen Mackay Simply click below to discover how you can take advantage of this. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Kirsteen Mackay | Saturday, 25th April, 2020 | More on: AGY
“COPY” Projects Social Housing Karspeldreef Block AB / Dick van Gameren architectenSave this projectSaveKarspeldreef Block AB / Dick van Gameren architecten Year: CopyAbout this officeDick van Gameren architectenOfficeFollow#TagsProjectsBuilt ProjectsSelected ProjectsResidential ArchitectureSocial HousingAmsterdamHousingThe NetherlandsPublished on September 21, 2011Cite: “Karspeldreef Block AB / Dick van Gameren architecten” 21 Sep 2011. ArchDaily. Accessed 12 Jun 2021.
Housing Cinematographer’s House and Studio / Inside Out Architecture ArchDaily United Kingdom Projects “COPY” “COPY” Photographs Architects: Inside Out Architecture Area Area of this architecture project Area: 263 m² Area: 263 m² Year Completion year of this architecture project 2012 Year: Cinematographer’s House and Studio / Inside Out ArchitectureSave this projectSaveCinematographer’s House and Studio / Inside Out Architecture ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/407762/cinematographer-s-house-and-studio-inside-out-architecture Clipboard ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/407762/cinematographer-s-house-and-studio-inside-out-architecture Clipboard Save this picture!© Ed Reeve+ 30 Share 2012 CopyHousing•Kilburn, United Kingdom photographs: Ed ReevePhotographs: Ed Reeve Save this picture!© Ed ReeveText description provided by the architects. The layout of the house is uniquely tailored to the client’s specific lifestyle and livelihood, with a number of unusual spaces including a high-spec cinema, a double height library and a renovated warehouse studio complimenting the more traditional domestic spaces.Save this picture!© Ed ReeveThe house’s picturesque urban setting adds to its singular character, sited on the edge of Kilburn Grange Park. A series of double-height sliding glazed screens take full advantage of these panoramic landscapes, with frameless corners eroding the division between house and park. Save this picture!© Ed ReeveThe ancillary spaces are, by contrast, quite tactile and personal. Intimate bathrooms are located within freestanding joinery pods while the narrowness and subdued lighting of the main staircase helps to create a dramatic sense of arrival as you step into any of the main spaces. While the oak and stone add a sense of warmth to the white interiors, the restrained material palette of the main spaces acts as a canvas for the ever-visible green landscape outside.Save this picture!SectionProject gallerySee allShow lessVan Alen Institute Announces Ground/Work Competition FinalistsArchitecture NewsAD Interviews: Reinier de GraafInterviewsProject locationAddress:Kilburn, London, United KingdomLocation to be used only as a reference. It could indicate city/country but not exact address. Share Year: CopyAbout this officeInside Out ArchitectureOfficeFollow#TagsProjectsBuilt ProjectsSelected ProjectsResidential ArchitectureHousingKilburnHousesUnited KingdomPublished on July 30, 2013Cite: “Cinematographer’s House and Studio / Inside Out Architecture” 30 Jul 2013. ArchDaily. Accessed 11 Jun 2021.
AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. Tagged with: Recruitment / people 22 total views, 1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Specialist charity lawyer Shivaji Shiva has joined Exeter-based Michelmores LLP as Head of Charity Law. He joins from Russell-Cooke solicitors in London, where he was a partner.Shivaji advises charities and other not-for-profit organisations on a variety of issues encompassing constitutional and governance advice, restructures and mergers, and a range of commercial work including service level agreements, fundraising agreements; grant agreements and intellectual property including copyright, trade mark and copyright.Malcolm Dickinson, head of Michelmore Business Team said: “Shivaji’s all-round commercial expertise will be of immense use to the charity sector which is a fast-growing practice area for the firm.”Shivaji said: “My aim is to combine that expertise with my own experience and my long-standing personal and professional commitment to the sector to develop an acknowledged centre of excellence for legal advice to charities and other voluntary organisations both in the South West and nationally.”www.michelmores.com Howard Lake | 17 January 2008 | News Charity law expert joins Michelmores
Equality watchdog to probe maternity discriminationOn 2 Mar 2004 in Personnel Today The EOC’s investigation into the unfair treatment of pregnant women byemployers is proving there is still a lot of work to be done before equality isensured. Roisin Woolnough reportsMany employers are still treating pregnant women unfairly, with pregnancy-relateddiscrimination generating more calls to the Equal Opportunities Commission(EOC) than any other subject. Since launching the UK’s first ever investigation into pregnant womensuffering discrimination at work in September 2003, it has received 240 calls.Of those calls, 45 per cent said they had been dismissed, threatened withdismissal or redundancy or felt forced into resignation because of theirpregnancy. More than 1,000 pregnancy-related unfair dismissal claims are lodged attribunals in England and Wales every year. Most are settled or withdrawn beforea full hearing. The discrimination seems to be happening across all sectors, although theinvestigation found that women aged under 25 in full-time employment, but withless than one year’s service, are the group most likely to lodge a complaint. The next stage of the investigation will focus on the employer’sperspective. Julie Mellor, chair of the EOC, believes there needs to be moresharing of best practice. “Clearly, some employers find it difficult tomanage pregnancy, particularly small employers,” she said. “But manyothers manage it successfully. Pregnant women who are treated fairly by theiremployers are more likely to go back to work after having children.” One good example is HSBC. After introducing family-friendly policies, thebank found that three times as many female staff returned to work after havinga baby. Fiona Cannon, head of equality and diversity at Lloyds TSB and chair ofthe investigation advisory board, said her bank had similar results. “We approach the whole work-life balance thing as one, with pregnancyas part of that,” she said. “As a result, our return rate aftermaternity leave is 90 per cent, having been 72 per cent eight to 10 yearsago.” Cannon advised pregnant women and their managers to discuss arrangements assoon as possible. “The earlier you have the conversation the better,because it means you can plan,” she explained. As soon as a womanannounces her pregnancy at Lloyds, they are issued with an information pack,which includes advice on how to stay fit and healthy. That positive attitude needs to be embedded in the corporate culture,according to Cannon. “Culture is the biggest thing,” she said.”Women have babies, they continue their careers – it’s no big deal.” Surinda Sharma, director of diversity at Ford Europe, said it is vital thatwomen are treated well in an industry that has problems attracting enough womenin the first place. “We also want to be an employer of choice,” hesaid. Recouping the investment Ford has made in training and developing staffis another strong consideration. “Our policy is geared towards keepingthem,” he added. However, the EOC research shows that many employers view pregnant women asan expensive liability, and pregnancy as an ‘illness’. One employer who spoketo the EOC during its investigation, said: “My company dreads an employeebecoming pregnant. Not only does the absence jeopardise the profitability ofthe business as a whole, but the employment of other staff due to lostbusiness. Small employers should have the right to terminate pregnant women’semployment.” The investigation is looking for employers, HR professionals and women witha story to contact it with their experiences. “We want to hear about any concernsfrom HR professionals. We’re looking for bad experiences and bestpractice,” said Cannon. Most women who suffer problems are dismissed before going on maternity leave– in some cases, within hours or days of informing their employer of theirpregnancy. There is a time limit of three months in the UK for making a claimof pregnancy discrimination. This means many women have to lodge theircomplaint either in the late stages of pregnancy, or soon after giving birth. Cannon said the investigation needs to establish whether the legal frameworkis sufficiently accessible. In France, for example, there is no time limit onbringing a claim to tribunal if a woman feels she has been discriminatedagainst. The UK offers women higher maternity leave entitlement than most otherEuropean countries. However, the amount of maternity pay is among the lowest inthe EU. It also lags behind its European counterparts in terms of childcareprovision. Mellor believes some employers worry that women will be less productiveafter having a child. To overcome that fear, she said that childcare optionsmust improve. “We need to catch up with the rest of Europe on that,”she said. www.eoc.org.uk/pregnantandproductiveE-mail: [email protected]’s pregnancy investigation2004 June/July – The employers’ perspective. NOP survey ofemployers to be released, highlighting the issues for employersSeptember – Interim report, with new research on pregnancy discrimination2005 January – Release of survey of 700 women February – Launch of final reportSource: Equal Opportunities Commission Previous Article Next Article Related posts:No related photos. Comments are closed.
Spiracle and tracheal structure in the extant Ixodida is revised and shown to comprise 29 distinct component characters, some of which are common to all Anactinotrichida, while others are unique to the Ixodida or one of its six component clades of ((Argasidae Nuttalliellidae) (Prostriata Metastriata)). Structural variation both between and within families is based upon combinations of minor differences in the component characters, only one of which, spiracular position, proved to be incongruent within the most parsimonious cluster- and tree-analysis solutions. Tracheal airflow in ticks is mediated via passive diffusion gradients. In the argasid spiracle, both aeropyles and ostium are functional, although the latter is only opened briefly during infrequent periods of activity. The ixodid ostium is sealed and all gas exchange takes place via an enlarged sieveplate which reduces transpiration via small aeropyles, an underlying dense array of pedicels and possibly hygroscopic sub-atrial glands. Changes in spiracular morphology from a more ‘ancestral’ argasid type to a more ‘derived’ ixodid type are correlated with changes in tick behaviour, particularly with increased activity associated with the change from nidicoly to host-seeking.
NOT every Blues squad can boast an ex-international with forty-three caps and three league titles, not to mention a hat-trick of FA Cups, spurring them on from the sidelines. In fact, this claim can only be made by Oxford’s footballers, who have the privilege of being coached by the former Arsenal centre back Martin Keown for the 2007/08 season. Oxford-born Keown, 41, is spending a year with the side as they look to make amends for last year’s Varsity defeat, on penalties, to Cambridge. The veteran defender is also taking his UEFA A coaching license whilst guiding the Blues through their debut season in the BUSA midlands top division.Watching the veteran defender stalk the touchline, pausing briefly to bark out instructions to his players, it was easy to imagine the man in his pomp, towering over strikers and intimidating the opposition with his sheer presence. After overseeing his side’s 2-1 win over Nottingham, including a backs-to-the-wall final twenty minutes, Keown revealed how his taking the reigns of Oxford football had come about.“It was actually me who approached the University” he said. “I rang up John Roycroft, Oxford’s Director of Sport, and asked him if there was any way in which I could help out with the football here.“The reason for approaching Oxford was that, besides being close to home, I’d have the opportunity to run the team and coach young players who are keen and willing to learn. It was also a good chance to gain real experience alongside taking my UEFA coaching badges.“Basically, I took this on to see whether I still love the game enough to go back into the professional side of things. This team is giving me my football fix at the moment and the experience of managing these players will be invaluable in the future.”The Highbury legend is not just here to further his own career, though. Keown enthused about bringing fresh players into the Blues set-up and appeared genuinely excited about helping to raise the profile of the sport in Oxford, and all the challenges that come with it. “The most difficult element so far was probably the system of trials that we held at the start of the season” he said. “I hadn’t experienced a situation like that in a long time, so we’ll probably be looking at changing that aspect of the system somehow.“What we don’t want is players slipping through the net as they’ve done in the past. There’s a lad called Cameron Knight, now in his third year, who only made his Blues debut this season. There has to be a better way of identifying talent throughout the university than the present trial system.”When pressed on which of his players have particularly caught his eye this term, Keown was quick to avoid singling out just one or two men. “We’re a team, not a group of individuals” he insisted.“It’s been hugely satisfying to see our improvement this term. The boys were beaten heavily by a representative side in our first game, but we’ve gone on to pick up some great results and challenge at the top of a tough division.”Away from the league, though, student eyes will surely be looking to Varsity and a triumph over the Tabs, although Keown played down the importance of the set-piece fixture. “I’m not just looking at this season in terms of Varsity” he said. “People will probably judge us on that one fixture, but in my eyes the sign of a quality team is showing consistency in the league.”Arsenal fans in particular will be keen to learn whether Keown’s chest-thumping, aggressive demeanour on the pitch has translated to his fledgling career in coaching. “I do try to be a bit calmer as a manager” he laughed. “What I like to see in football is composure on the ball and then aggression when you are trying to get it back. I always want to see my players putting in 100% effort out on the pitch, and thankfully the lads here have never given me less than that.”Keown was turning out for local side Marston Saints when he was spotted by Arsenal, launching him on the way to a glittering career. Who’s to say, with the Blues riding high in their league and the man himself clearly relishing being back in the sport, that a second life in coaching won’t also begin with an amateur side in Oxford?